{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:05Z","timestamp":1791618965336,"version":"4.3.4"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aims to analyze the disease burden and trends of malignant neoplasm of bone and articular cartilage (MNBAC) in Chinese children from 1990 to 2021 using data from GBD 2021, and to compare them with the United States and India.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data on incidence, prevalence, mortality, and disability-adjusted life years (DALYs) for MNBAC in children aged 0\u201314 years were extracted from GBD 2021. The joinpoint regression analysis model was employed to assess temporal trends, and the average annual percent change (AAPC) was calculated to summarize the trends over the study period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Globally, the number of incident childhood cases of MNBAC increased from 9,827 in 1990 to 12,294 in 2021, with an AAPC of 0.38. Similarly, the prevalence of the disease also increased, with an AAPC of 0.39. However, the mortality rate and DALYs rate showed a slight decline, with an AAPC of \u22120.16 and \u22120.16 respectively. At the national level, the United States had the highest incidence and prevalence rates, while India had the highest number of incident cases and DALYs. China showed the largest increase in prevalence, with an AAPC of 1.88. India also demonstrated the most significant decline in mortality and DALYs rates. Additionally, the mortality rate and DALYs rate were slightly higher for male children compared to female patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Malignant bone and articular cartilage tumors in children remain a significant public health challenge globally. By strengthening monitoring, increasing investment in medical resources, promoting early screening and intervention, and enhancing international cooperation and exchange, we hope to further reduce the burden of childhood bone cancer and improve children's quality of life and health standards.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1481304","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:28:00Z","timestamp":1751520480000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Disease burden and trends of malignant neoplasm of bone and articular cartilage in childhood in China, 1990\u20132021 and comparison with United States and India: findings from the Global Burden of Disease Study 2021"],"prefix":"10.3389","volume":"13","author":[{"given":"Ruibo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S1470-2045(19)30339-0","article-title":"The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017","volume":"20","year":"2019","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet."},{"key":"B3","unstructured":"Bone cancer: diagnosis and treatment principles\n          \n          205\n          13\n          \n            \n              Ferguson\n              JL\n            \n            \n              Turner\n              SP\n            \n          \n          Am Fam Physician.\n          98\n          2018"},{"key":"B4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3238\/arztebl.m2023.0079","article-title":"The diagnosis and treatment of osteosarcoma and ewing's sarcoma in children and adolescents","volume":"120","author":"Zarghooni","year":"2023","journal-title":"Dtsch Arztebl Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e29442","DOI":"10.1002\/pbc.29442","article-title":"Current approaches to management of bone sarcoma in adolescent and young adult patients","volume":"69","author":"Ingley","year":"2022","journal-title":"Pediatr Blood Cancer."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.908955","article-title":"The systematic analysis and 10-year prediction on disease burden of childhood cancer in China","author":"Zhu","year":"2022","journal-title":"Front Public Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"GBD","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1002\/sim.9407","article-title":"Twenty years since Joinpoint 10: two major enhancements, their justification, and impact","volume":"41","author":"Kim","year":"2022","journal-title":"Stat Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0302140","DOI":"10.1371\/journal.pone.0302140","article-title":"Global burden of rheumatoid arthritis among adolescents and young adults aged 10-24 years: a trend analysis study from 1990 to 2019","volume":"19","author":"Li","year":"2024","journal-title":"PLoS ONE."},{"key":"B12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S2352-4642(22)00219-X","article-title":"Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10-24 years from 1990 to 2019: a trend analysis based on the Global Burden of Disease Study 2019","volume":"6","author":"Zhang","year":"2022","journal-title":"Lancet Child Adolesc Health."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1002\/cncr.34163","article-title":"Osteosarcoma: a surveillance, epidemiology, and end results program-based analysis from 1975 to 2017","volume":"128","author":"Cole","year":"2022","journal-title":"Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends-an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamasurg.2018.0501","article-title":"Practical guide to surgical data sets: surveillance, epidemiology, and end results (SEER) database","volume":"153","author":"Doll","year":"2018","journal-title":"JAMA Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S1470-2045(20)30073-5","article-title":"Cancer registration in China and its role in cancer prevention and control","volume":"21","author":"Wei","year":"2020","journal-title":"Lancet Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"910641","DOI":"10.3389\/fpubh.2022.910641","article-title":"Global, regional, and national burden of cancer in children younger than 5 years, 1990-2019: analysis of the global burden of disease study 2019","volume":"10","author":"Ren","year":"2022","journal-title":"Front Public Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MOP.0000000000000984","article-title":"Global health disparities in childhood cancers","volume":"33","author":"Lubega","year":"2021","journal-title":"Curr Opin Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-072X-11-24","article-title":"It's a long, long walk: accessibility to hospitals, maternity and integrated health centers in Niger","volume":"11","author":"Blanford","year":"2012","journal-title":"Int J Health Geogr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/MPH.0b013e31816e22f3","article-title":"Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data","volume":"30","author":"Esiashvili","year":"2008","journal-title":"J Pediatr Hematol Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1200\/JCO.22.02767","article-title":"Prognostic factors in high-grade osteosarcoma of theextremities or trunk: an analysis of 1,702 patients treatedon neoadjuvant cooperative osteosarcoma study group protocols","volume":"41","author":"Bielack","year":"2023","journal-title":"J Clin Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.20892\/j.issn.2095-3941.2022.0231","article-title":"Current cancer burden in China: epidemiology, etiology, and prevention","volume":"19","author":"Maomao","year":"2022","journal-title":"Cancer Biol Med."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1481304\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:28:05Z","timestamp":1751520485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1481304\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":22,"alternative-id":["10.3389\/fpubh.2025.1481304"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1481304","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"article-number":"1481304"}}